New study to reveal hidden effects of Weight-Loss drug on joints and heart
NCT ID NCT07567378
First seen May 07, 2026 · Last updated Jun 17, 2026 · Updated 9 times
Summary
This study observes 30 adults in Mexico who are already taking tirzepatide (a diabetes/weight-loss drug) to see how it impacts knee cartilage, heart fat, and body composition over 52 weeks. Researchers will use advanced MRI and CT scans, along with blood tests and body measurements, to understand the drug's effects beyond weight loss. No new treatments are given; participants continue their regular care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
IMSS Clínica Río Magdalena
Mexico City, Mexico City, 01090, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.